Plot No.367, Abhey Pur, Industrial Area Phase-1, Panchkula, Haryana 134109
Don't miss out on this limited-time offer to join our successful PCD Pharma network. Fill in your details below and our team will get in touch with you to discuss the best franchise opportunities tailored to your needs.
Composition : Eltrombopag (50mg) Tablet
Dosage Form : Tablet
Packaging Type : Alu Alu
Packaging : 2x7
Price : ₹0/-
Eltrombopag 50 mg Tablet is a thrombopoietin receptor agonist indicated for the management of chronic immune thrombocytopenia (ITP) and thrombocytopenia associated with chronic hepatitis C. It supports an increase in platelet count and helps reduce the risk of bleeding.
The medication works by stimulating thrombopoietin receptors in the bone marrow, promoting platelet production without suppressing immune function. This targeted action makes it suitable for patients requiring controlled platelet elevation.
Clinically, Eltrombopag 50 mg Tablet is prescribed for patients with persistently low platelet counts who do not respond adequately to first-line therapies, supporting stable hematological outcomes under specialist supervision.
With its importance in long-term hematology treatment and consistent prescription demand, this therapy helps strengthen specialty medicine portfolios and supports sustained growth by addressing critical platelet management needs in clinical practice.
Common side effects may include headache, nausea, diarrhea, fatigue, and upper respiratory tract infections. Rarely, elevated liver enzymes, thromboembolic events, or cataract formation may occur.
Eltrohype 50 Tablet is indicated for the treatment of chronic immune thrombocytopenia (ITP) in patients who have had an insufficient response to corticosteroids, immunoglobulins, or splenectomy. It is also used in thrombocytopenia associated with chronic hepatitis C and severe aplastic anemia as prescribed by a physician.
Use this medicine strictly under medical supervision. Regular monitoring of platelet count and liver function tests is essential during treatment. Do not exceed the recommended dosage. Inform the doctor about any history of liver disease or clotting disorders.
Store below 25°C in a cool, dry place. Protect from light and moisture. Keep out of reach of children.
Composition : Faropenem (200mg)
Composition : Faropenem (300mg)
Composition : Levofloxacin (250mg) Tablet
Composition : Levofloxacin (250mg) + Ornidazole (500mg)
Composition : Levofloxacin (500mg)
Composition : Levofloxacin (750mg)
Composition : Moxifloxacin (400mg)
Composition : Nitrofurantoin (100mg) Tablet
Composition : Norfloxacin (400mg) + Tinidazole (600mg)
Composition : Ofloxacin (200mg)